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ABSTRACT 
 
High Resolution Microendoscopy for Quantitative Diagnosis of Esophageal Neoplasia 
 
by 
 
Dongsuk Shin 
 
Esophageal cancer is the eighth most common cancer in the world.  Cancers of 
the esophagus account for 3.8% of all cases of cancers, with approximately 482,300 new 
cases reported in 2008 worldwide.  In the United States alone, it is estimated that 
approximately 18,000 new cases will be diagnosed in 2013, and 15,210 deaths are 
expected.  Despite advances in surgery and chemoradiation therapy, these advances have 
not led to a significant increase in survival rates, primarily because diagnosis often at an 
advanced and incurable stage when treatment is more difficult and less successful.  
Accurate, objective methods for early detection of esophageal neoplasia are needed. 
Here, quantitative classification algorithms for high resolution miscroendoscopic 
images were developed to distinguish between esophageal neoplastic and non-neoplastic 
tissue.  A clinical study in 177 patients with esophageal squamous cell carcinoma (ESCC) 
was performed to evaluate the diagnostic performance of the classification algorithm in 
collaboration with the Mount Sinai Medical Center in the United States, the First Hospital 
of Jilin University in China, and the Cancer Institute and Hospital, the Chinese Academy 
of Medical Science in China.  The study reported a sensitivity and specificity of 93% and 
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92%, respectively, in the training set, 87% and 97%, respectively, in the test set, and 84% 
and 95%, respectively, in an independent validation set.   Another clinical study in 31 
SDWLHQWV ZLWK %DUUHWW¶V HVRSKDJXV UHVXOWHG LQ a sensitivity of 84% and a specificity of 
85%.  Finally, a compact, portable version of the high resolution microendoscopy 
(HRME) device using a consumer-grade camera was developed and a series of 
biomedical experimental studies were carried out to assess the capability of the device. 
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1.  INTRODUCTION  
1.1  Objective and Specific Aims 
During endoscopic examination of the esophagus, lesions which appear to be suspicious 
are biopsied and then examined histologically.  Although patients with esophageal cancer 
benefit from endoscopic screening, this procedure fails to detect many esophageal 
cancers.  High-resolution optical imaging techniques have the potential to improve 
diagnostic accuracy to detect pre-cancerous and cancerous lesions by visualizing 
subcellular changes of tissue.  Confocal endomicroscopy has demonstrated the capacity 
to provide high-quality imaging; however, use of this technique requires expensive and 
complex hardware and specialized equipment.  In contrast, high-resolution 
microendoscopy provides subcellular imaging through a fiber-optic bundle and uses a 
wide-field epifluorescence arrangement instead of point scanning, which reduces system 
complexity and cost.  The objective of this research is to develop a portable, cost-
effective, high-resolution microendoscope and quantitative analysis criteria for the 
diagnosis of esophageal neoplasia and to evaluate its diagnostic potential in clinical 
studies. 
 
The specific aims of this research are:  
1) Develop an automated analysis algorithm for high-resolution microendoscopic images 
for the quantitative diagnosis of esophageal squamous neoplasia, and evaluate its 
diagnostic performance through a multicenter, in vivo clinical study.  The clinical study 
will be performed at the Mount Sinai Medical Center in the United States, the First 
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Hospital of Jilin University in China, and the Cancer Institute and Hospital, the Chinese 
Academy of Medical Science in China. 
2) Develop quantitative analysis criteria based on high-resolution microendoscopic 
LPDJHVIRUWKHGHWHFWLRQRIHVRSKDJHDO%DUUHWW¶VQHRSODVLDDQGHYDOXDWHWKHLUGLDJQRVWLF
accuracy through a prospective study.  The clinical study will be performed at the Mount 
Sinai Medical Center. 
3) Design and construct a portable, cost-effective, high-resolution microendoscope using 
a consumer-grade camera, and evaluate its performance through a series of experimental 
studies. 
1.2  Overview 
This dissertation describes the development of quantitative classification algorithms for 
high resolution microendoscopy for diagnosis of esophageal neoplasia and the 
development of a compact high resolution microendoscope using a comsumer-grade 
camera.  The dissertation is organized as follows. 
 Chapter 1 lists the specific aims of the research and provides a brief overview of 
the topics to be discussed. 
 Chapter 2 provides background information on esophageal cancer, progression of 
esophageal cancer, methods for detection and diagnosis, and optical diagnostic 
techniques.  Confocal endomicroscopy and high resolution microendoscopy for diagnosis 
of esophageal cancer are reviewed. 
 Chapter 3 describes a clinical study of the diagnostic performance of a 
quantitative classification algorithm in 177 patients with esophageal squamous cell 
carcinoma.  The development of an automated diagnostic algorithm is described.  
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Diagnostic performance is evaluated in a training set and test set, and in an independent 
validation set.  Optimum features for diagnostic classification are identified. 
 Chapter 4 describes a clinical study of the diagnostic performance of a 
quantitative classification algorithm in 31 patients with Barrett¶s esophagus.  The 
development of an automated diagnostic algorithm is described.  Diagnostic performance 
is evaluated using sequential classification analysis.  Optimum features for diagnostic 
classification are identified.. 
 Chapter 5 describes the design and construction of a compact, portable HRME 
device.  Evaluation of its performance through a series of experimental studies.is 
described. 
 Chapter 6 summarizes the results of the various studies and concludes with a 
discussion of the status of high resolution microendoscopy for diagnosis of esophageal 
neoplasia. 
Chapter 7 lists references cited. 
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2.  BACKGROUND 
2.1  Motivation and significance  
Esophageal cancer is the sixth most common cause of cancer-related mortality worldwide 
[1, 2]. Despite advances in chemoradiation therapy, the 5-year survival rate remains at a 
dismal 15%, primarily due to diagnosis at an advanced and incurable stage [3].  Indeed, 
survival rates drop dramatically once the tumor has breached the mucosal layer, 
reinforcing the importance of early detection. 
While the disease carries a significant global burden (including in the United States), 
certain geographic areas, such as Iran, Central Asia, and northern China, have a 
particularly high incidence of esophageal squamous cell carcinoma (ESCC).  The reasons 
for this are multifactorial, and many social and environmental factors have been 
implicated, including smoking, alcohol consumption, low socioeconomic status, thermal 
injury/hot beverage consumption, and nutritional deficiencies [2].  In northern China, 
age-standardized incidence rates exceed 100/100,000 per year [2, 4], making it an ideal 
setting for evaluation and intervention.  In these regions, screening and surveillance 
practices have been implemented with limited success, and the incidence-to-mortality 
ratio still remains a grim 1:1 [5].  On the other hand, esophageal adenocarcinoma (EAC) 
DULVLQJLQ%DUUHWW¶VHVRSKDJXV%(LVPRUHSUHYDOHQWLQWKH Western World, especially in 
the United States, and has a fast growing incidence rate, with an estimated 600% increase 
from 1975 to 2001 [1-3]. 
Although a combination of early diagnosis through endoscopic surveillance and 
improved treatments at an early stage increases the 5-year survival rate of EAC to 80%, 
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most cases are diagnosed at an advanced stage when treatment is challenging because 
symptoms tend to manifest late and current detection methods have limitations [6, 7]. 
2.2  Progression of esophageal neoplasia 
Normal esophageal tissue is characterized histologically with hematoxylin and eosin 
(H&E) staining by stratified squamous epithelium, as shown in Figure 1a. Esophageal 
neoplasia mostly falls into either ESCC or EAC. There are major differences between the 
two in terms of progression. ESCC is preceded by dysplasia and EAC is preceded by BE. 
ESCC is believed to develop through a sequence of dysplastic precursor lesions, 
beginning with mild, moderate, and then severe dysplasia, carcinoma in situ (CIS), and 
finally ESCC, as shown in Figure 1 [8, 9]. Squamous dysplasia, which is the most well-
described risk factor for ESCC, is characterized by the presence of loss of normal cell 
polarity, abnormal tissue maturation, and nuclear atypia, such as enlargement, 
pleomorphism, and hyperchromasia in the lower one-third (mild; Figure 1b), in the lower 
two-thirds (moderate; Figure 1c), or in all the thirds (severe; Figure 1d) of the epithelium. 
Squamous carcinoma in situ is characterized by the presence of dysplastic squamous cells 
throughout the full thickness of the epithelium, as shown in Figure 1e. Squamous cell 
carcinoma is characterized by the presence of neoplastic squamous cells invading the 
basement membrane, as shown in Figure 1f. 
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In contrast, EAC typically arises in BE, which is characterized by the 
transformation of squamous epithelium to intestinal metaplasia near the gastroesophageal 
junction and is often caused by gastroesophageal reflux disease. This intestinal-type 
epithelium progresses sequentially from metaplasia, low-grade dysplasia, high-grade 
dysplasia, and finally to EAC, as shown in Figure 2 [10, 11]. BE is confirmed 
histologically by the identification of goblet cells within glands (Figure 2a). Low-grade 
dysplasia, which is difficult to distinguish from non-dysplastic BE, is characterized by 
nuclear crowding and some loss of nuclear polarity (Figure 2b). High-grade dysplasia is 
characterized by the overall loss of nuclear polarity and glandular structure, nuclear and 
glandular crowing, and especially the absence of goblet cells (Figure 2c). EAC is 
characterized by abortive formation of glands (Figure 2d).  
Normal epithelium Mild dysplasia Moderate dysplasia 
A B C
Severe dysplasia Carcinoma in situ 
Squamous cell 
carcinoma 
D E F
Figure 1. Progression of (a) normal squamous epithelium to (b) mild dysplasia, (c) moderate 
dysplasia, (d) severe dysplasia, (e) carcinoma in situ, and (f) squamous cell carcinoma. 
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2.3  Current and emerging methods for screening and diagnosis 
To date, endoscopic screening ZLWK /XJRO¶V LRGLQH LV ZLGHO\ XVHG WR GHWHFW VTXDPRXV
neoplasia, with targeted biopsy of unstained (abnormal) areas [12-14]. Typically, 
screening is performed in patients considered ³high risk´ LH those with a history of 
head and neck malignancy, positive balloon cytology, and who live in high-prevalence 
regions such as northern China, Central Asia, and Iran [2] :KLOH /XJRO¶V
chromoendoscopy can highlight large areas that need further evaluation, it is limited by 
its poor specificity [15-17].  Indeed, inflammation and other abnormalities may often 
mimic neoplasia, leading to high false false-positive rates.  Other novel ³wide-field´ 
imaging modalities, such as autofluorescence imaging and narrow-band imaging, have 
been proposed as ³red flag´ WHFKQLTXHVEXWDUHOHVVVHQVLWLYHWKDQ/XJRO¶VVWDLQLQJ [16] 
and limited by high false-positive rates due to their low spatial resolution [17]. As a 
result, several unnecessary biopsies are taken, resulting in an increase in cost and risk. 
Endoscopy with random four-quadrant biopsies for surveillance of BE with or 
without dysplasia is the accepted method for screening esophageal adenocarcinoma [18, 
%DUUHWW¶VHVRSKDJXV 
%DUUHWW¶VHVRSKDJXV
with low-grade 
dysplasia 
%DUUHWW¶VHVRSKDJXV
with high-grade 
dysplasia 
Esophageal 
adenocarcinoma 
A D B C 
Figure 2. 3URJUHVVLRQ RI D %DUUHWW¶V HVRSKDJXV WR E ORZ-grade dysplasia, (c) high-grade dysplasia, and (d) 
adenocarcinoma. 
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19].  However, since a segment of BE can range from 1 to 20 cm, systematic, four 
quadrant biopsies at 2-cm intervals leave the majority of the BE epithelium untested and 
can miss dysplasia and early cancer, which are often focal, flat, and not visible on routine 
endoscopy [20].  
Advances in optical imaging techniques have facilitated efforts to utilize these 
techniques for diagnostic guidance of different pathological conditions.  In particular, 
high-resolution optical imaging techniques have the potential to improve diagnostic 
accuracy to detect precancerous and cancerous lesions by visualizing subcellular changes 
of tissues in patients with esophageal neoplasia.  These techniques include confocal 
endomicroscopy and fiber-optic high-resolution microendoscopy. 
Confocal laser microendoscopy provides subcellular views of the esophageal 
epithelium and the ability to differentiate esophageal neoplasia from benign esophageal 
mucosa, with high diagnostic accuracy during endoscopy in near real time [21-31].  
Previous studies have shown the ability of the confocal laser endomicroscope to 
successfully detect ESCC in vivo during endoscopy, allowing microscopic examination 
throughout the esophagus [21-24].  Deinert et al. investigated the capability of a confocal 
laser endomicroscope system to identify changes in the microvascular architecture of 
esophageal squamous epithelium in a patient with ESCC [21].  In a study by Liu et al. 
[22], confocal laser endomicroscopy was used to characterize alterations in cells and 
intrapapillary capillary loops in normal and ESCC.  Diagnostic accuracy in distinguishing 
cancerous from normal epithelium was examined in 64 sites from 57 patients, resulting in 
a sensitivity of 79.4% and a specificity of 90%.  In a pilot study of 43 sites from 21 
patients [23], Iguchi et al. demonstrated that confocal microscopy could identify 
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esophageal squamous neoplasia by characterizing cellular and vascular patterns; a 
sensitivity of 100% and 88%, and a specificity of 94% and 90% were achieved by two 
endoscopists, respectively.  Pech et al. examined 43 sites from 21 patients with suspected 
ESCC using a confocal laser microendoscope [24].  Suspicious areas identified by 
chromoendoscRS\ZLWK/XJRO¶VLRGLQHZHUHLQYHVWLJDWHGXVLQJFRQIRFDOLPDJLQJ$OO
neoplastic sites were diagnosed correctly and 2 of 16 non-neoplastic sites were diagnosed 
falsely as neoplastic, resulting in a sensitivity of 100% and a specificity of 87.5%. 
Studies of patients with BE have also reported promising results with the use of 
confocal microendoscopy [25-31].  Kiesslich et al. [25] showed that confocal 
microendoscopy detected BE and BE-associated neoplasia, with a sensitivity of 98.1% 
and 92.9%, respectively, and a specificity of 94.1% and 98.4%, respectively, by 
identifying cellular and vascular changes in the BE epithelium.  Pohl et al. [26] evaluated 
the use of confocal endomicroscopy in the detection of neoplasia in 296 sites from 38 
patients with BE.  Confocal imaging criteria for advanced BE neoplasia were first 
established in 95 sites from 15 patients, and were then tested on 201 sites from 23 
patients without visible mucosa abnormalities.  The results showed a sensitivity of 80% 
and a specificity of 94.1%, with a corresponding negative predictive value of 98.9%.  
Similarly, Gaddam et al. [27] established confocal imaging criteria for dysplastic BE 
using 50 confocal images and then evaluated accuracy and interobserver agreement using 
70 testing confocal images.  The sensitivity and specificity in diagnosing dysplasia were 
76% and 85%, and the interobserver agreement among six endoscopists was substantial 
(ț = 0.61).  In a study involving 11 expert endoscopists [28], Wallace et al. performed a 
preliminary evaluation of confocal laser endomicroscopy in a training and validation set 
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of 20 BE images, and yielded a sensitivity of 88% and a specificity of 96%.  The study 
reported substantial interobserver agreement of the confocal endomicroscopy diagnosis 
(86%; ț  0.72).  In a prospective, randomized, double-blind, controlled, crossover study 
of 39 patients [29], confocal laser endomicroscopy with targeted mucosal biopsy was 
shown to improve the diagnostic yield of BE-associated neoplasia compared to standard 
endoscopy with a four-quadrant, random biopsy (33.7% vs. 17.2%).  In an international 
multicenter, prospective, randomized, controlled study of 101 patients [30], Sharma et al. 
demonstrated that confocal endomicroscopy coupled with high-definition white-light 
endoscopy (HD-WLE) dramatically improved the ability to detect BE-associated 
neoplasia.  Sensitivity was higher with the combination compared to HD-WLE alone 
(68.3% vs. 34.2%), while specificity was slightly lower (87.8% vs. 92.7%).  
However, although confocal microendoscopic imaging has been shown to have the 
potential to significantly improve detection of esophageal neoplasia, current confocal 
platforms are expensive, thus making this technology only available to tertiary referral 
centers. 
Fiber-optic high-resolution microendoscopy (HRME), an alternative to confocal 
endomicroscopy, has also been used to detect esophageal neoplasia in previous studies 
[32-36]. Muldoon et al. investigated the feasibility of HRME to image a variety of 
esophageal tissue types, including squamous tissue, BE, and neoplastic tissue obtained by 
endoscopic resection [33].  In a small pilot study of 9 patients with BE, Muldoon et al. 
demonstrated that HRME imaging could distinguished neoplastic from non-neoplastic 
tissue, with a sensitivity of 87% and a specificity of 85% [34].  In an in vivo case study of 
a patient with BE, Pierce et al. showed the ability of HRME to distinguish high-grade 
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dysplasia from normal squamous mucosa and BE without dysplasia [35].  Recently, Vila 
et al. assessed accuracy and interrater agreement in identifying BE-associated neoplasia 
using 40 HRME images from 28 patients [36].  A sensitivity of 90% and a specificity of 
82% were achieved, and no significant differences in accuracy were found between 
experts and novices (ț = 0.56).  HRME imaging also provides a relevant subcellular 
structure established for confocal microendoscopy and the ability to distinguish between 
esophageal neoplasia and benign esophageal mucosa, with high diagnostic accuracy 
during endoscopy.  This low-cost (<$5,000) system may be useful as an adjunct to 
standard endoscopy in the screening and surveillance of esophageal neoplasia in a low-
resource or community-based setting. 
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3. ANALYSIS OF HIGH RESOLUTION MICROENDOSCOPIC IMAGES FOR 
AUTOMATED DIAGNOSIS OF ESOPHAGEAL SQUAMOUS CELL CARCINOMAa 
aThe contents of this chapter are being prepared for submission to the journal The Journal of National 
Cancer Institute with the following author list:  Shin D, Protano M-A, Polydorides AD, Dawsey SM, Pierce 
MC, Kim MK, Schwarz RA, Quang T, Parikh N, Bhutani MS, Zhang F, Wang G, Xue L, Wang X, Xu H, 
Anandasabapathy S, Richards-Kortum RR (2013) 
 
 
Abstract:  High resolution microendoscopy is an optical imaging technique with 
the potential to improve the accuracy of endoscopic screening for esophageal 
squamous neoplasia.  In this study we developed quantitative image analysis 
criteria for the evaluation of neoplastic and non-neoplastic squamous esophageal 
mucosa.  Patients undergoing standard upper GI endoscopy for screening or with 
known esophageal lesions were additionally imaged in vivo using high resolution 
microendoscopy.  A total of 375 sites in 177 patients were imaged and analyzed.  
Quantitative information from the high resolution images was used to develop an 
automated algorithm to identify high-grade squamous dysplasia or invasive 
squamous cell cancer and compared to histopathology as the gold standard.  
Optimal performance was obtained using mean nuclear area as the basis for 
classification, resulting in sensitivities and specificities of 93% and 92% in the 
training set, 87% and 97% in the test set, and 84% and 95% in an independent 
validation set, respectively.  This study demonstrates that high resolution 
microendoscopy with automated image analysis can aid in the identification of 
esophageal squamous neoplasia. 
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4.1  Introduction 
There is an urgent global need to improve early diagnosis of esophageal squamous cell 
carcinoma (SCC) [1, 2, 37].  The five-year survival rate of esophageal SCC in the United 
States is only 19%, primarily because diagnosis is often at an advanced and incurable 
stage [38]. In low-resource settings, the five-year survival is much lower; for example, in 
Golestan Province, Iran, it is 3.4% [39].  At present, the most widely used and most 
VHQVLWLYH PHWKRG RI HQGRVFRSLF VFUHHQLQJ IRU VTXDPRXV QHRSODVLD LQYROYHV /XJRO¶V
iodine staining of the esophagus with targeted biopsy of areas that do not retain dye [22-
24] +RZHYHU VSHFLILFLW\ RI /XJRO¶V FKURPRHQGRVFopy is poor [32-34].  Areas of 
inflammation often appear indistinguishable from superficially invasive carcinoma, 
leading to high false positive rates. Confocal microendoscopy, a high resolution imaging 
technique which evaluates the epithelium at 1100x magnification, has revolutionized 
endoscopic surveillance for neoplasia by allowing detection at the subcellular level [22, 
2@:KHQ FRQIRFDO LPDJLQJ LV SDLUHG ZLWK /XJRO¶V FKURPRHQGRVFRS\ DFFXUDF\ UDWHV
have been shown to rise to nearly 95% with a dramatic improvement in specificity [24].  
However, existing platforms are both expensive ($150,000-$300,000) and available only 
in a handful of tertiary centers worldwide.  
Thus, there remains an important need for easily accessible complementary high 
resolution LPDJLQJWHFKQRORJLHVWKDWFDQLPSURYHWKHDFFXUDF\RI/XJRO¶VE\HQKDQFLQJ
specificity, reducing the false positive rate, and reducing the number of biopsies needed 
for accurate patient diagnosis.  In particular, there is a need for low cost imaging 
platforms that are robust, accurate, and reproducible when used in lower resource settings 
where there is frequently a shortage of healthcare providers.   For this purpose, we 
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recently developed a fiber-optic high resolution microendoscope (HRME).  The HRME 
provides images of the surface epithelium with similar resolution to confocal 
microendoscopy, but with significantly reduced system complexity and cost [32].  Recent 
studies conducted with the HRME demonstrated that sub-cellular resolution morphology 
can be usHG WR GHWHFW QHRSODVWLF OHVLRQV LQ SDWLHQWV ZLWK %DUUHWW¶V HVRSKDJXV >33, 34], 
breast carcinoma [40], cervical carcinoma [41, 42] and oral squamous cell carcinoma 
[43]. 
The goal of the present study was to develop quantitative HRME image analysis 
criteria for the delineation of neoplastic and non-neoplastic squamous esophageal 
mucosa. In an ongoing clinical trial, HRME images were obtained during white light and 
/XJRO¶VFKURPRHQGRVFRS\IURPDUHDVGHHPHGHQGRVFRSLFDOO\QRUPDOLQGHWHUPLQDWHDQG
suspicious for neoplasia.  Quantitative image analysis was used to develop an automated 
algorithm which was optimized using data from a training set, and the accuracy of the 
algorithm was evaluated relative to the reference standard of histopathology using data 
from independent test and validation sets.  Features used in the automated algorithm were 
also used to develop guidelines for the visual interpretation of HRME images in vivo. 
3.2  Methods 
3.2.1  Patients 
Study participants previously scheduled to undergo screening for ESCC or 
surveillance for known squamous cell dysplasia underwent standard white light upper GI 
HQGRVFRS\ ZLWK /XJRO¶V ,RGLQH  :ULWWHQ LQIRUPHG FRQVHQW ZDV REWDLQHG IURP HDFK
subject.  The study was reviewed and approved by the Institutional Review Boards at The 
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First Hospital of Jilin University in China, The Cancer Institute at The Chinese Academy 
of Medical Sciences in China, The Mount Sinai Medical Center, and Rice University.   
The endoscopist recorded the location and level, and clinical impression of each 
/XJRO¶VXQVWDLQHGDUHD/XJRO¶VQHJDWLYHDUHDVWKDWZHUHLQGHWHUPLQDWHRUVXVSLFLRXVIRU
neoplasia were then further interrogated with a high resolution micro-endoscope 
(HRME); the fiber-optic HRME system is described in detail below.  Prior to HRME 
imaging at each site, a topical solution (1- 2 ml) of 0.01% proflavine (P2508, Sigma-
Aldrich, St. Louis, MO) in sterile phosphate buffered saline was applied to the 
esophageal surface using a spray catheter; proflavine, which was used under an 
Investigational New Drug (IND) application from the Food and Drug Administration 
(IND 102 217), is a fluorescent contrast agent which stains cell nuclei [44].  The 
esophagus was rinsed with saline (1-2 ml) and residual liquid on the surface was 
suctioned.  Following application of proflavine, the fiber-optic probe of the HRME was 
immediately inserted through the biopsy channel of the endoscope and the distal tip was 
placed in gentle contact with the mucosal surface.  Real-time imaging was performed; at 
each site between 1 and 113 video sequences of approximately 1-3 seconds duration were 
acquired and were stored as movie files.  HRME images were also obtained from two 
/XJRO¶VVWDLQHG³QRUPDO´DUHDVIURP each patient.  At each site imaged with the HRME, 
WKHILEHUSUREHZDVXVHGWRPDNHDVXSHUILFLDOGLPSOHWR³PDUN´WKHLPDged area for later 
biopsy.  Each imaged site was then biopsied and submitted for routine histologic 
diagnosis.  All of the specimens were processed and sectioned in a standardized manner.  
Slides were later reviewed by two expert gastrointestinal pathologists (AP, SD) blinded 
WR WKH HQGRVFRSLVWV¶ FOLQLFDO LPSUHVVLRQV DQG WR WKH +50( LPDJHV  'LDJQRVLV ZDV
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performed using standard histologic criteria [45]; based on histologic diagnosis, samples 
were divided into the following categories: normal, inflammation, low-grade dysplasia 
(LGD), moderate-grade dysplasia (MGD), high-grade dysplasia (HGD), or cancer.  Sites 
with discrepant diagnoses were reviewed by both pathologists to reach consensus.  Sites 
initially diagnosed as moderate-grade dysplasia were later re-reviewed independently by 
both pathologists, and consensus was reached to diagnose these sites as either LGD or 
HGD depending on whether dysplasia was confined to the lower 1/2 of the epithelium 
(LGD) or not (HGD). 
3.2.2  Imaging System 
The HRME system has been described in detail previously [46].  Briefly, the 
system acquires fluorescence images via a coherent fiber bundle placed in contact with 
the tissue surface to be imaged.  Illumination is provided via a bandpass-filtered blue 
light-emitting diode (LED) (FF01-452/25, Semrock, Rochester, NY; M455L2, Thorlabs, 
Newton, NJ).  Light is reflected at a dichroic mirror (485DCLP, Chroma Technology 
Corp, Bellows Falls, VT) onto a 1 mm outer diameter fiber bundle (FIGH-30-850N, 
Fujikura, Tokyo, Japan), which is comprised of 30,000 optical fibers with a center-to-
center spacing of 4 µm and a 720 µm field of view (FOV).  Fluorescence emission 
returning through the fiber bundle is imaged through the dichroic mirror and a 550 nm 
bandpass filter (FF03-550/88, Semrock, Rochester, NY) onto the optical sensor of a CCD 
camera (GRAS-14S5M, Point Grey, Richmond, Canada). The lateral and axial resolution 
of the system are 4.4 and 20 µm, respectively. The system is controlled by a laptop 
computer which acquires and displays video at a frame rate of 15 frames per second. 
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3.2.3  Automated Image Analysis 
Videos acquired with the HRME were reviewed for quality control (QC) purposes 
by three observers (RRK, MP, MAP) who were blinded to clinical impression and 
pathologic diagnosis.  First, one reviewer (MP) identified a single representative image 
frame from each video sequence.  Selected images were then reviewed for QC 
independently by all three reviewers.  Images were rejected if at least 50% of the FOV 
was out of focus, showed evidence of motion artifact, or was obscured by debris at the tip 
of the fiber bundle.  At each site, images which met the QC process were then reviewed 
to select the single image with the highest visual image quality. 
 
 
Figure 3. Automated image analysis process. 1) A region of interest (ROI, yellow outline) is selected 
automatically, excluding image regions which are saturated (red outline) or too dim (purple outline). 2) 
Fiber pattern is removed using Gaussian filtering. 3) Nuclei are segmented. 4) Quantitative image features 
are calculated (e.g. nearest internuclear distance). 
   
Images were processed to extract image features of potential use in a 
classification algorithm.  Figure 3 illustrates the image analysis procedure used in this 
study.  While HRME images can reveal important information about epithelial cell 
morphology and tissue architecture, there are frequently regions of the image which may 
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be too dim for analysis due to uneven contact of the distal fiber tip with the epithelium, or 
may be saturated due to the presence of small pieces of debris at the probe tip.  Images 
were first analyzed to exclude such areas of the image and identify an informative region 
of interest (ROI) for each image.  Regions to be excluded were identified by applying a 
low-pass filter to highlight homogeneous regions of similar intensity and then 
thresholding the image to reject areas which were too dim or bright for further analysis.  
Following selection of the informative ROI to be analyzed, Gaussian spatial filtering was 
applied to remove the background pattern associated with the structure of the fiber bundle 
used for HRME imaging [47].  Morphologic image processing and thresholding were 
used to segment nuclei in the HRME image.  Morphologic processing (opening and 
smoothing) was used to compensate for the non-uniform background.  Once a threshold 
was determined by the histogram-based thresholding method, nuclear and cytoplasmic 
regions were separated by the threshold.  
Following nuclear segmentation, the mean, standard deviation, and coefficient of 
variation of the following features which characterize nuclear morphology were 
calculated for each image: nuclear size, nuclear-to-cytoplasmic area ratio (N/C ratio),  
nearest internuclear distance, nuclear eccentricity, nuclear solidity, and major axis of the 
ellipse best approximating each nucleus. 
3.2.4  Automated Image Classification 
Features extracted from the HRME images were then used to develop and 
evaluate an automated classification algorithm to classify whether each site imaged 
contained neoplastic tissue (HGD, cancer) or was non-neoplastic (normal, inflammation, 
LGD).  The data obtained at The First University Hospital and The Mount Sinai Medical 
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Center were randomly divided into a training set used to develop and optimize the 
algorithm, and an independent test set used to estimate algorithm performance.  
Approximately 1/2 of the images were randomly assigned to the training set and 1/2 to 
the test set.  Randomization was repeated until the proportion of neoplastic sites was 
approximately the same in the training and validation sets.  All images from a single 
patient were assigned to either the training set or the test set.  The data obtained at The 
Cancer Institute at The Chinese Academy of Medical Sciences were assigned to an 
independent validation set. 
  Two-class linear discriminant analysis was used to develop a classification algorithm 
using data only from the training set; image features were added one at a time until 
classification performance did not improve further.  Histologic diagnosis was considered 
to be the gold standard.  The receiver operating characteristic (ROC) curve for this 
classifier was plotted using training set data and the optimal threshold was established at 
the Q-point of the ROC curve.  The classification algorithm was then used to classify data 
in the test and validation sets using this threshold.  Sensitivity and specificity were 
calculated using histologic diagnosis as the gold standard.  Finally, ROC curves were 
plotted for the algorithm applied to the test and validation sets. 
3.3  Results 
3.3.1  Subject Information ± Patients and Sites 
A total of 215 subjects were enrolled in the study; images with corresponding 
pathology results were available from 448 sites in 194 patients.  Three reviewers 
independently agreed on selection of representative images from 303 sites, with 25 of 
these not passing QC review.  In the 145 sites where reviewers disagreed, consensus was 
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reached on 137 sites, with 40 of these not passing QC review.  Images for the remaining 
8 sites where consensus could not be reached were not included in further analysis.  The 
remaining data set for further analysis consisted of images from 375 sites in 177 patients. 
Table 1 shows the histological diagnosis of the measured sites which passed QC review. 
The data obtained at The First University Hospital and The Mount Sinai Medical Center 
were randomly separated into training and test sets; 104 sites from 54 patients were 
assigned to the training set and 104 sites from 45 patients were assigned to the test set.  
All sites from a single patient were assigned to either the training or test set.  The 
remaining data obtained at The Cancer Institute at The Chinese Academy of Medical 
Sciences were assigned to an independent validation set which consisted of 167 sites 
from 78 patients.  The composition of the training, test, and validation sets is summarized 
in Table 2. 
 
Table 1. Histopathologic diagnosis of measured sites. 
 
Histopathology diagnosis Sites 
Non-neoplastic 
Normal 198 
Inflammation 76 
Low-Grade Dysplasia 52 
Neoplastic 
High-Grade Dysplasia 31 
Cancer 18 
 
Total 375 
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Table 2. Training set and validation set composition 
 
  
Histopathologic diagnosis 
# of 
patients 
# of 
sites 
Non-neoplastic 
 
Neoplastic 
Normal Inflammation 
Low-Grade 
Dysplasia  
High-Grade 
Dysplasia 
Cancer 
Training 54 104 70 13 6 
 
8 7 
Test 45 104 70 13 6 
 
8 7 
Validation 78 167 58 50 40 
 
15 4 
         
Total 177 375 198 76 52 
 
31 18 
 
3.3.2  Quantitative Classification Performance 
Quantitative image features were calculated using the automated image analysis.  
Figure 4 illustrates bar graphs of the mean quantitative image feature values for 
neoplastic and non-neoplastic tissue in the training set.  P values were obtained with the 
Mann-Whitney U test.  The average feature values of non-neoplastic were significantly 
different from the feature values of neoplastic for all the features. 
A two-class linear discriminant algorithm was developed to separate neoplastic 
and non-neoplastic tissue using each of these six features.  The single best performing 
feature was found to be the mean nuclear area.  Figure 5(a) depicts a scatter plot of this 
feature for each analyzed site in the training set.  The decision line associated with the 
two-class linear discriminant classifier is shown as a straight line on the plot; the 
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algorithm results in a sensitivity of 93% and a specificity of 92%.  Figure 5(b) and 5(c) 
illustrate this feature for each site in the test and validation sets; the decision line 
developed using the training set is also shown.  Applying the algorithm to data in the test 
set results in a sensitivity of 87% and a specificity of 97%, and applying it to the data in 
the validation set results in a sensitivity of 84% and a specificity of 95%.   Figure 6 
shows the associated ROC curves for this algorithm.  The area under the ROC curve is 
0.92 in the training set, 0.95 in the test set, and 0.93 in the validation set.  The addition of 
multiple features did not improve algorithm performance. 
 
 
Figure 4. Bar graphs indicating mean values of six quantitative image features (± one std. dev) for non-
neoplastic and neoplastic sites in the training set. P-values were obtained using the Mann-Whitney U test. 
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Figure 5. (a) Scatter plot of mean nuclear area for each measured site in the training set.  The decision line 
which classifies sites as neoplastic or non-neoplastic with maximum accuracy is shown.  (b) Scatter plot of 
mean nuclear area for each measured site in the test set. (c) Scatter plot of mean nuclear area for each 
measured site in the validation set. The decision line to classify sites as neoplastic or not using the training 
set is shown. 
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Figure 6. ROC curves for linear discriminant analysis algorithm based on the single feature of mean nuclear 
area applied to data in (a) the training set, (b) the test set, and (c) the validation. The Q-points correspond to 
a sensitivity of 93% and a specificity of 92% in the training set (a), 87% and 97% in the test set (b), and 84% 
and 95% in the validation set (c). 
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3.4  Discussion 
This study assessed the feasibility of automated analysis of HRME images for detection 
of esophageal squamous neoplasia.  Using image analysis tools, we extracted quantitative 
image features.  Data from a training set were used to develop an automated algorithm to 
discriminate neoplastic from non-neoplastic tissues; data from a test set and an 
independent validation set were used to evaluate the performance of this algorithm.  
Mean nuclear area was the image feature with the best performance to discriminate non-
neoplastic and neoplastic esophageal squamous epithelium, resulting in a sensitivity of 
87% and a specificity of 97% in the test set and 84% and 95% in the validation set 
compared to the reference standard of histopathology.   
Given the limitations of existing screening approaches, the limited availability 
and high cost of current high resolution platforms, and the uniformly poor prognosis of 
invasive esophageal carcinoma, there is a great need for more accurate and widely 
available technologies, particularly in low and middle income countries with high rates of 
esophageal cancer.  A robust, low-cost method of detecting squamous cell neoplasia at an 
early, resectable stage could markedly improve existing endoscopic screening, 
surveillance and treatment.  While preliminary, the high accuracy and specificity of 
quantitative analysis of HRME images demonstrated here suggest that this technique 
could potentially be used to more accurately and selectively target biopsy location.  This 
could reduce the number of biopsies needed for accurate patient diagnosis in low-
resource settings where the pathology processing and reading costs are an especially large 
part of the total cost of patient evaluation and diagnosis.  Additionally, the ability to 
delineate normal from neoplastic mucosa in real-time, if this can be achieved, may 
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enhance endoscopic margin detection, enabling greater accuracy for complete resection 
by minimally-invasive endoscopic therapies such as endoscopic mucosal resection, a less 
costly and less morbid alternative to surgical esophagectomy [48].  
The use of automated image analysis potentially reduces the need to train 
endoscopists to interpret HRME images.   It is well known that human interpretation is 
subject to inter-observer and intra-observer variability, which can limit diagnostic 
performance [49-51].  Classification based on digital image processing has the potential 
to reduce the variability of human diagnostic accuracy by providing an objective means 
to interpret digital images with consistency.  This may prove particularly useful in low 
resource settings where experienced personnel are limited. 
The strengths of this study include the fact that it was a multi-center, in vivo study 
with data from the first two clinical sites randomized to a training set for algorithm 
development and a separate test set to evaluate the performance of the algorithm relative 
to the gold standard of histopathology.  In addition, performance of the algorithm was 
assessed in an independent validation set acquired in a different clinical setting than the 
training and test sets.   
A limitation of this study is that image analysis was not performed in real time.  
Instead, images were analyzed post-hoc, following image acquisition.  Furthermore, not 
all steps of the image analysis procedure were automated.  Before the process can be 
implemented in real-time, it will be necessary to automate frame selection and QC 
procedures.   
Alternatively, the algorithm developed here could be used to enable computer 
assisted visual image analysis, with automated frame-by-frame analysis supplemented 
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with visual QC guidance.  Figure 7 shows a simple example of how the results of the 
automated image analysis presented here can be used to guide the development of visual 
image interpretation guidelines to assist endoscopists in classifying HRME images of the 
esophagus.  Mean nuclear area was found to be the best performing image feature, with 
samples classified as neoplastic if mean nuclear area exceeds 180 µm2 (Fig. 5a); this 
corresponds to a mean nuclear diameter  of 15.1 µm assuming circular nuclei.  As a 
simple way to extend this approach to visual image interpretation, we added a row of 
15.1 µm diameter dots to the top of each HRME image; in addition, we superimposed a 
grid with lines spaced 19.4 µm apart to facilitate estimation of nuclear size across the 
image.  Observers are presented an image with the dots and grid superimposed and asked 
to visually assess whether most nuclei are larger than 15.1 µm in diameter; if yes, then 
the site is diagnosed as neoplastic.  The visual image interpretation guide is now 
embedded in the HRME imaging software and superimposed on an image window to 
assist clinicians in identifying neoplastic lesions in real-time at the time of endoscopy. 
In summary, the HRME with quantitative image analysis appears to be a promising 
adjunct that can improve the endoscopic detection of esophageal squamous neoplasia 
with high accuracy.  The lower cost of the technology and the potential for objective 
image interpretation suggest that it may be feasible for use in low-resource settings.  
Further analysis is necessary to assess diagnostic accuracy in real time and to determine 
whether this approach is cost-effective in such settings. 
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Figure 7. Flow chart illustrating visually-guided image analysis algorithm. A row of 15.1 µm diameter dots 
was added to the top of each HRME image; in addition, a grid with lines spaced 19.4 µm apart was 
superimposed to facilitate estimation of nuclear size across the image. If most nuclei appear smaller than 
15.1µm in diameter, then the image is classified as non-neoplastic; otherwise it is classified as neoplastic. 
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4.  ANALYSIS OF HIGH-RESOLUTION MICROENDOSCOPIC IMAGES FOR 
48$17,7$7,9(',$*126,62)1(23/$6,$ ,13$7,(176:,7+%$55(77¶6
ESOPHAGUSb 
bThe contents of this chapter are being prepared for submission. 
 
Abstract: 
Background:  This study describes an approach for quantitative image analysis of 
PLFURHQGRVFRSLF LPDJHV WR LGHQWLI\ QHRSODVWLF OHVLRQV LQ SDWLHQWV ZLWK %DUUHWW¶V
esophagus. This quantitative computer-aided image classification algorithm has the 
potential to improve diagnostic performance. 
Methods:  77 sites in 31 patients were imaged with a fiber optic high-resolution 
microendoscope (HRME) during a standard endoscopic procedure. Images were analyzed 
by a fully-automated image processing algorithm, which automatically selected a region 
of interest (ROI) and calculated quantitative image features. Image features were used to 
develop an algorithm to identify the presence of neoplasia; results were compared to 
histopathology diagnosis. 
Results:  A sequential classification algorithm that utilized image features related to 
glandular and cellular morphology resulted in a sensitivity of 84% and a specificity of 
85%.   
Conclusions:  This in vivo study demonstrates that high-resolution microendoscopic 
imaging can be used to identify esophageal neoplasia with high accuracy.  Automated 
sequential analysis of microendoscopic images can provide an objective, quantitative 
framework to assist clinicians in evaluating esophageal lesions from patients with 
%DUUHWW¶VHVRSKDJXs. 
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4.1  Introduction 
+LJKO\SUHYDOHQWLQWKH86SRSXODWLRQ%DUUHWW¶VHVRSKDJXV%(LVDPDMRUULVN factor for 
the development of esophageal adenocarcinoma (EAC). The incidence rate of EAC is 
rapidly increasing in the Western World, with an estimated 600% increase in incidence 
over the last 40 years [1-3, 37].  Moreover, most cases of EAC are diagnosed at a late 
stage when treatment is challenging, resulting in significant morbidity and a poor 5-year 
survival rate [52]. Early diagnosis of neoplasia in patients with BE is challenging. Even 
with routine endoscopic surveillance, it is difficult to identify areas of dysplasia or 
neoplasia because they may be focal and flat and not visible on standard endoscopy. 
Endoscopy with random four-quadrant biopsies is the accepted surveillance of BE for 
identifying the presence of dysplasia. However, four-quadrant biopsies every 2 cm of the 
%DUUHWW¶VPXFRVDFDQVDPSOHRQO\DVPDOO IUDFWLRQRI WKHHQWLUHVHJPHQWRI%(UDQJLQJ
from 1 to 20 cm, often resulting in sampling error.  Random biopsy protocols have been 
shown to miss greater than 50% of neoplasia [20, 53]. Improving early detection of BE-
associated neoplasia is, therefore, critical to improve survival and quality of life for 
patients. 
Coupled with standard endoscopy, high-resolution optical imaging technologies 
have the potential to improve diagnostic accuracy for the detection of precancerous and 
cancerous lesions in patients with BE by allowing real-time imaging with resolution that 
approaches that of conventional histopatholoty. Confocal microendoscopy can 
GLVWLQJXLVK HVRSKDJHDO QHRSODVLD IURP EHQLJQ %DUUHWW¶VPucosa with high accuracy by 
providing images of tissue architecture and cellular morphology with subcellular 
resolution throughout the esophageal epithelium. In several studies, confocal 
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endomicroscopy combined with high-definition white-light endoscopy (HD-WLE) was 
shown to significantly improve the ability to detect BE-associated neoplasia [25, 30]. 
Despite the potential for improving detection of esophageal neoplasia, current confocal 
platforms are only available to tertiary referral centers due to extremely high-cost 
($150,000-$300,000). We recently developed a low-cost (<$5,000) fiber-optic high-
resolution microendoscope (HRME), capable of imaging tissue with subcellular 
resolution comparable to confocal microendoscopy [32]. Muldoon et al. showed the 
feasibility of the HRME to image various esophageal tissue types, including squamous, 
BE, and high-grade dysplastic tissue obtained by endoscopic mucosal resection [33]. 
Pierce et al. demonstrated the ability of the HRME to differentiate high-grade dysplasia 
from normal squamous mucosa and BE without dysplasia in vivo from a patient with BE 
[35]. 
Most studies of high resolution endoscopic imaging rely on subjective visual 
interpretation. Inter- and intra-observer variability in the assessment of images impair 
reliable diagnosis.  Quantitative analysis offers an objective manner to examine images; 
the use of computer-aided algorithms may reduce subjectivity among reviewers and 
enhance reproducibility, resulting in improving diagnostic accuracy.  Such algorithms can 
be coupled with advanced optical imaging techniques with the potential to allow real-
time in vivo diagnosis with high accuracy.   
In this paper, we report a algorithm to analysis HRME images from patients with BE to 
distinguish neoplastic from non-neoplastic esophageal mucosa.  The sequential 
classification algorithm was developed based on the sequential rules that expert observers 
used to classify images based on visual assessment. Performance of the algorithm was 
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compared with both visual assessment and histopathology, Results demonstrate improved 
diagnostic performance when using the sequential automated classification algorithm to 
detect esophageal neoplasia in BE. 
4.2  Methods 
4.2.1  Patients 
3DWLHQWV ZLWK NQRZQ %( RU %DUUHWW¶V ZLWK G\VSODVLD ZKR were scheduled for 
routine surveillance endoscopy were recruited for this study. Study participants were at 
least 18 years old and signed a written informed consent and authorization. Persons who 
were unfit for standard upper endoscopy were ineligible for the study. The study was 
reviewed and approved by the Institutional Review Boards at Mount Sinai Medical 
Center and Rice University. 
$QHQGRVFRSLVWSHUIRUPHGDVWDQGDUGXSSHUHQGRVFRSLFH[DPLQDWLRQ$UHDVRI%DUUHWW¶V
mucosa suspicious for neoplasia during endoscopy were further interrogated with the 
HRME. Prior to HRME imaging, a topical solution (1-2 ml) of 0.01% proflavine in 
sterile PBS was applied to the esophageal surface using a standard endoscopic spray 
catheter. Proflavine, which was used under an Investigational New Drug (IND) 
application from the Food and Drug Administration (IND 102 217), is a fluorescent 
contrast agent which stains cell nuclei [44]. Following application of proflavine, the 
fiber-optic probe of the HRME was inserted through the biopsy channel of the 
endoscope, and the distal tip was placed in gentle contact with the mucosal surface. Real-
time imaging was performed; at each site, video sequences of approximately 3-seconds 
duration were acquired and then saved to a file. HRME images also were obtained from 
at least two of four sites selected for random quadrant biopsy. At each site imaged with 
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WKH+50(WKHILEHUSUREHZDVXVHGWRPDNHDVXSHUILFLDOGLPSOHWR³PDUN´WKHLPDJHG
area. Each imaged site was then biopsied and submitted for routine histologic diagnosis. 
The endoscopist completed a standard of care evaluation by taking the remaining biopsies 
of the routine four-quadrant biopsy procedure and submitting these for routine histologic 
diagnosis. All of the specimens were processed and sectioned in a standardized manner. 
Slides were later reviewed by an expert gastrointestinal pathologist (AP) blinded to the 
HQGRVFRSLVW¶V FOLQLFDO LPSUHVVLRQV 'LDJQRVLV ZDV SHUIRUPHG XVLQJ VWDQGDUG KLVWRORJLF
criteria [45]; based on histologic diagnosis, samples were divided into the following 
FDWHJRULHV VTXDPRXVPXFRVD JDVWULF FDUGLD %DUUHWW¶VPHWDSODVLD ORZ-grade dysplasia 
(LGD), high-grade dysplasia (HGD), or adenocarcinoma. 
4.2.2  Imaging System 
The HRME system has been previously described in detail [46]. A bandpass-
filtered blue light emitting diode (LED) (FF01-452/25, Semrock, Rochester, NY; 
M455L2, Thorlabs, Newton, NJ) provides light that passes through a dichroic mirror 
(485DCLP, Chroma Technology Corp, Bellows Falls, VT) onto a fiber bundle (FIGH-30-
850N, Fujikura, Tokyo, Japan) with a 1-mm outer diameter that is placed in contact with 
the tissue surface to be imaged. The fiber bundle is composed of 30,000 optical fibers 
with a 4-µm center-to-center spacing and a 720-µm field of view (FOV). Fluorescence 
emission returns through the fiber bundle and is imaged through the dichroic mirror and a 
550-nm bandpass filter (FF03-550/88, Semrock, Rochester, NY). The emission then 
passes onto the optical sensor of a charge-coupled device (CCD) camera (GRAS-14S5M, 
Point Grey, Richmond, Canada). The system has a lateral and axial resolution of 4.4 and 
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20 µm, respectively. A laptop computer controls the system obtains and displays video at 
a rate of 15 frames per second. 
4.2.3  Flowchart for Visual Classification of HRME Images of the Esophagus 
HRME images were reviewed for quality control (QC) purposes by two reviewers 
(RRK, ML). First, one reviewer (ML) identified a single representative image frame from 
each video sequence. Second, selected images were then reviewed independently for QC 
by the two reviewers who were blinded to clinical impression and histologic diagnosis. 
Images were rejected if at least 50% of the FOV was out of focus or showed evidence of 
motion artifact. Lastly, images that met QC were then reviewed for the selection of a 
single image with the best image quality per site. 
Two reviewers familiar with HRME images of BE from prior studies [35, 47] 
were asked to classify each image acquired in this study as neoplastic or non-neoplastic. 
They were blinded to histopathology diagnosis. To assist in the classification, each image 
was printed on a 3x5 card and reviewers arranged cards according to classification. 
Reviewers were interviewed following the exercise to understand the sequential rules 
they used in classification. A flowchart was created to represent the sequential steps 
followed in visual assessment. The flowchart consisted of decision nodes structured in 
the form of yes or no questions that led to a specific answer choice. Each question was 
chosen to describe differences in cell type, cell morphology, and glandular structures, 
subsequently leading to each category, and then used to extract relevant image features 
for the following classification analysis. 
We also evaluated whether this flowchart could aid endoscopists in making 
correct visual reads with HRME images of the esophagus. The digital HRME images 
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were reviewed by three endoscopists with HRME experience. Using the flowchart, 
reviewers reviewed the entire set of images and recorded an impression for each image as 
RQHRIWKHILYHFDWHJRULHV7KHFDWHJRULHVIRUVTXDPRXVPXFRVD%DUUHWW¶VPHWDSODVLDDQG
gastric cardia were considered to be non-neoplastic, while the remaining categories were 
considered neoplastic. Results of visual image interpretation using the flowchart were 
calculated for each reviewer. 
4.2.4 Automated Image Analysis 
Figure 8 illustrates the quantitative image analysis procedure used in this study. 
At each image, the whole circular FOV was selected for analysis. Low-pass Gaussian 
filtering was applied to remove the background pattern associated with the structure of 
the fiber bundle used for HRME imaging [54]. Because the images acquired in this study 
exhibited different morphologic structures associated with squamous epithelium, 
intestinal metaplasia, and neoplasia, a variety of image features were explored. First, 
image intensity was calculated as a feature that could potentially be used to separate 
squamous tissue from glandular tissue because the fluorescent intensity of glands might 
be higher than that of squamous-cell nuclei. Second, images were segmented to identify 
cell nuclei. Morphologic image processing and thresholding were used to segment nuclei 
in each HRME image. Morphologic processing (opening and smoothing) was used to 
compensate for the nonuniform background. Once a threshold was chosen by the 
histogram-based automated thresholding method, nuclear and cytoplasmic regions were 
separated by the threshold. Following nuclear segmentation, nuclear-to-cytoplasmic area 
ratio (N/C ratio), mean nuclear size, and mean nearest internuclear distance were 
calculated for each image.  
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Lastly, granulometry was used to characterize epithelial thickness and lumen size 
of glands. Granulometry is a morphologic method to calculate the size distribution of 
objects in an image without explicitly segmenting each object [18]. HRME images of 
glandular epithelium exhibit dark lumens with bright epithelial lining.  The size 
distribution of epithelial layer was calculated from each HRME image.  Similarly, the 
size distribution of mucosal lumens was calculated from the inverse of each HRME 
image.  From granulometry, the most frequent size, kurtosis, and skewness of the 
distribution of the following features were computed for each image: epithelial thickness 
and mucosal lumen size. 
 
 
 
Figure 8.  Image analysis process 
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4.2.5 Automated Image Classification 
Features extracted from the HRME images were then used to develop and 
evaluate an automated sequential classification algorithm to classify whether each imaged 
site contained neoplastic tissue (HGD or cancer) or was non-neoplastic (normal 
VTXDPRXV PXFRVD JDVWULF FDUGLD %DUUHWW¶V PHWDSODVLD RU /*' (DFK step of the 
classification algorithm was identified from the corresponding decision node of the 
flowchart developed from visual assessment. Two-class linear discriminant analysis was 
used to develop a classification algorithm at each step; extracted image features were 
added one at a time until classification performance no longer improved. Sensitivity and 
specificity were calculated using the sequential classification algorithm and histologic 
diagnosis as the gold standard. 
4.3  Results 
4.3.1 Subject Information: Patients and Sites 
A total of 36 subjects were enrolled in this study, and 115 sites from 33 patients 
had corresponding pathology results. Two reviewers (RRK, ML) selected representative 
images from 87 sites that passed QC review; 28 did not pass QC review. The expert 
pathologist (AP) reviewed the selected images to see whether they showed different 
morphology from the histologic diagnosis; 10 sites did not pass QC review. The 
remaining data set for the subsequent analysis consisted of 77 images from 77 sites in 31 
patients. Of these sites, 58 were diagnosed as non-neoplastic and 19 were diagnosed as 
neoplastic. Table 3 shows the histological diagnosis of the measured sites. 
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Table 3.  Histopathology diagnosis of measured sites. 
 
4.3.2 Visual Interpretation Using Flowchart 
Figure 9 shows the sequential flowchart that was developed for visual 
classification. Images were categorized into one of five categories. The first question 
categorized the images based on the presence or absence of glandular tissue. Images that 
were categorized as not containing glandular tissue were further classified based on the 
presence of nuclear crowding. Among the images that were categorized as containing 
glandular tissue, those that contained glandular epithelium with a thin epithelium and 
large lumen were first separated. The rest of the images were then categorized based on 
the preservation of regular architecture within the glandular epithelium. 
4.3.3 Classification Performance 
Quantitative image features were calculated. Relevant image features were 
selected as described to develop a sequential classification algorithm with optimal 
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performance. Figure 10 illustrates a classification tree and shows the performance of each 
node in the tree. At Node 1 of the classification tree, the most frequent epithelial 
thickness and intensity of the epithelial layer were chosen to classify whether each image 
contained glandular tissue or not. At Node 2, the N/C ratio was chosen to classify each 
image into neoplastic or non-neoplastic squamous tissue. The most frequent lumen size 
and kurtosis of lumen size were chosen at Node 3 to classify each image as cardia or not. 
The skewness of epithelial thickness was chosen at Node 4 to classify each image into 
neoplastic or non-neoplastic glandular tissue. Using the sequential classification criteria, 
16 of 19 sites were correctly classified as neoplastic, and 49 of 58 sites were correctly 
classified as non-neoplastic, resulting in a sensitivity of 84% and a specificity of 85%. 
 
Figure 9.  Flowchart for visual classification. Scale bar: 100µm. 
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Figure 10.  Classification performance 
 
4.4  Discussion 
In this study, we demonstrated that HRME imaging could discriminate BE with neoplasia 
from benign esophageal tissue including normal squamous, BE without dysplasia, and 
BE with low-grade dysplasia using quantitative image analysis and sequential 
classification analysis.  A classification algorithm was created by sequential analysis of 
image features within the images, which represented differences in cell type, cell 
morphology, and glandular structures between non-neoplastic and neoplastic esophageal 
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tissue.  The sequential classification algorithm was able to distinguish between neoplastic 
and neoplastic tissue with a sensitivity of 84% and a specificity of 85%. 
In several studies with confocal endomicroscopy, confocal imaging criteria for 
BE neoplasia were established and evaluated.  Pohl et al. [27] evaluated the use of 
confocal endomicroscopy in the detection of neoplasia in 296 sites from 38 patients with 
BE, and achieved a sensitivity of 80% and a specificity of 94.1%, with a corresponding 
negative predictive value of 98.9%.  Similarly, in a study conducted by Gaddam et al. 
[28], confocal imaging criteria for dysplastic BE were established and evaluated using 50 
confocal images, resulting in a sensitivity of 76% and a specificity of 85%.  Wallace et al. 
[51] established confocal imaging criteria in a training set of 20 BE images and tested in 
an independent validation set of 20 BE images.  The study reported a sensitivity of 88% 
and a specificity of 96%.  Although confocal microendoscopy has shown high accuracy 
for detection of neoplasia, however, inter- and intra-observer variability exist in the 
interpretation of images obtained with such technique [33, 49, 50].  Rigorous diagnostic 
criteria using quantitative image analysis can reduce this subjectivity and provide 
consistent diagnosis with high accuracy.  Muldoon et al. developed quantitative image 
analysis criteria for HRME images from either endoscopically-resected or biopsied tissue 
to distinguish between neoplastic and non-neoplastic esophageal mucosa [47].  The 
quantitative analysis using textural features within the images achieved a sensitivity of 
87% and a specificity of 85%, while human analysis for the same images achieved 
average sensitivity and specificity of 87% and 53%, respectively. 
The quantitative classification algorithm described in this paper has the potential 
to improve the accuracy and reproducibility for detection of esophageal neoplasia by 
42 
 
providing an objective means to classify images with consistency.  This approach may be 
of use to clinicians, especially in low-resource settings.  Also, it is noted that this 
sequential classification algorithm used intuitive image features which corresponded well 
to ones used for visual interpretation of the HRME images, such as epithelial cell 
morphology and glandular architecture of BE.  Alternatively, a framework based on this 
quantitative classification algorithm can potentially assist endoscopists in the 
interpretation of HRME images with high accuracy and consistency. 
Several other studies have also proposed quantitative analysis of HRME images 
for diagnosis of neoplasia in patients with oral neoplasia [43, 55] and cervical neoplasia 
[41, 42].  Analysis used in these studies, however, employed nuclear segmentation to 
distinguish differences in cell morphology of neoplastic tissue.  It is difficult to extend 
this approach to analysis of images from patients with neoplasia in the glandular 
epithelium, which exhibits differences in not only nuclear morphology but also glandular 
architecture [35, 36].  The quantitative classification algorithm presented here could be 
applied to any analysis of HRME images of the glandular epithelium where a variety of 
tissue types exist.  Furthermore, confocal imaging of the gastrointestinal epithelium could 
be advantaged by this quantitative classification analysis. 
A limitation of this study is the small field of view (720 µm in diameter) of the 
HRME.  Often, dysplastic changes in BE occur focally; the HRME may not image the 
area of dysplasia correctly.  This might be, also, because the positioning of the HRME 
probe during endoscopy is difficult at BE.  Considerable training on the endoscopic 
positioning of the HRME probe will be necessarily required for better diagnostic yield. 
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The use of the HRME and quantitative diagnostic algorithm presented here could 
potentially impact the application of high-resolution microendoscopy as a useful tool in 
low-resource settings by providing a cost-effective and reliable method for detecting 
esophageal neoplastic lesions during endoscopy.  Further evaluation of this classification 
algorithm in real-time will be necessary in clinical practice, particularly in resource-poor 
settings. 
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5.  A FIBER-OPTIC FLUORESCENCE MICROSCOPE USING A CONSUMER-
GRADE DIGITAL CAMERA FOR IN VIVO CELLULAR IMAGINGc 
cThe contents of this chapter have been published in the following journal article:  Shin D, Pierce MC, 
Gillenwater AM, Williams MD, Richards-Kortum RR.  A fiber-optic fluorescence microscope using a 
consumer-grade digital camera for in vivo cellular imaging.  PLoS One. 2010;5(6):e11218. 
 
 
Abstract:  Early detection is an essential component of cancer management.  
Unfortunately, visual examination can often be unreliable, and many settings lack 
the financial capital and infrastructure to operate PET, CT, and MRI systems.  
Moreover, the infrastructure and expense associated with surgical biopsy and 
microscopy are a challenge to establishing cancer screening/early detection 
programs in low-resource settings.  Improvements in performance and declining 
costs have led to the availability of optoelectronic components, which can be used 
to develop low-cost diagnostic imaging devices for use at the point-of-care.  Here, 
we demonstrate a fiber-optic fluorescence microscope using a consumer-grade 
camera for in vivo cellular imaging.  The fiber-optic fluorescence microscope 
includes an LED light, an objective lens, a fiber-optic bundle, and a consumer-
grade digital camera. The system was used to image an oral cancer cell line 
labeled with 0.01% proflavine.  A human tissue specimen was imaged following 
surgical resection, enabling dysplastic and cancerous regions to be evaluated.  The 
oral mucosa of a healthy human subject was imaged in vivo, following topical 
application of 0.01% proflavine.  The fiber-optic microscope resolved individual 
nuclei in all specimens and tissues imaged.  This capability allowed qualitative 
and quantitative differences between normal and precancerous or cancerous 
tissues to be identified.  The optical efficiency of the system permitted imaging of 
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the human oral mucosa in real time.  Our results indicate this device as a useful 
tool to assist in the identification of early neoplastic changes in epithelial tissues.  
This portable, inexpensive unit may be particularly appropriate for use at the 
point-of-care in low-resource settings. 
9.1  Introduction 
Point-of-care diagnostic devices should be small, inexpensive, and portable, yet accurate, 
robust, and simple to use. Optical imaging techniques can play a crucial role in the 
realization of such technologies, by providing real-time, high-resolution diagnostic 
information in non- or minimally-invasive fashion. In addition, flexible, miniature fiber-
optic components have made it possible to access tissue at confined sites within the body, 
enabling cellular level imaging to be performed in tandem with standard wide-field 
methods, such as endoscopy. These capabilities are currently being investigated for 
potential roles in clinical diagnostics, screening, and surgical guidance [32, 33, 56-62], 
but for translation of the technology to the point-of-care setting to become realistic, issues 
of cost, complexity, size, and performance must be addressed. 
Rapid improvements in the technical specifications and cost efficiency of 
consumer-grade electronics have brought high-performance imaging devices to the 
general market. Low-cost, high-quality digital cameras are now available with over 20 
megapixel image sensors (for example the Canon EOS-1Ds mark III); Sony-Ericsson's 
Satio model cellular phone has 12.1 megapixels. SLR (Single Lens Reflex) digital 
cameras are relatively inexpensive in comparison to the scientific-grade CCD cameras 
which are used in many biological imaging applications [63-65]. Most of these cameras 
are powered by a rechargeable battery pack and include a built-in LCD screen for real-
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time visualization. These features can support the design of imaging systems that are low-
cost, battery-powered and completely portable. Indeed, studies have employed digital 
SLR cameras for macroscopic image acquisition of biological tissues [66-69], and also 
for recording images of cells and tissue sections on conventional and portable 
microscopes [70]. 
Microscopic scale imaging in vivo has thus far been developed through 
techniques such as confocal microscopy, using flexible, narrow fiber-optic probes to 
access superficial tissues such as the skin, or hollow cavities such as the oral cavity, 
bronchus, cervix or GI tract [32, 33, 56-59]. While these systems have demonstrated the 
capacity to provide high-quality images, the requirements of laser sources, scanning 
mechanism(s), and high-speed digitizing hardware all contribute to a price tag well out of 
the range of many healthcare settings. Our group [32], [33], and others [56], [60], [62] 
have recently demonstrated sub-cellular resolution wide-field imaging through a fiber-
optic bundle. By using a wide-field epi-fluorescence arrangement instead of point-
scanning, the system complexity and cost are greatly reduced. When used with bright, 
fluorescent contrast agents, sub-cellular morphology can be viewed in real-time, by 
simply placing the distal end of the bundle onto the tissue site to be imaged. 
Here we present a high-resolution fiber-optic fluorescence imaging system using a 
consumer-based digital camera to visualize sub-cellular features in living tissue. We 
demonstrate the capabilities of the system through a series of experimental studies. First, 
we carried out imaging of a cultured cell model of an oral cancer cell line labeled with 
fluorescent dye. Next, we performed imaging of a surgically-resected human tissue 
specimen, including dysplastic and cancerous regions. Finally, a healthy human subject 
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was imaged in vivo. These studies demonstrate the capability of the system to obtain 
images with sub-cellular resolution, non-invasively, and in real-time. We propose that 
this portable, inexpensive diagnostic imaging device may be useful as an efficient 
diagnostic tool at the point-of-care for populations in remote or rural communities in the 
U.S. as well as in developing countries. 
9.2  Materials and methods 
Fiber-optic microendoscope system using a consumer-grade digital camera 
The main components of the system include an LED light source, a microscope 
objective lens, a fiber bundle and a digital camera as shown in Figure 11. The LED light 
source emits an optical spectrum centered at 455 nm with 20 nm spectral bandwidth (full-
width half-maximum). Following a 450 nm bandpass filter (Thorlabs, FB450-40) and a 
475 nm dichroic mirror (Chroma, 475DCXRU), excitation light illuminates the proximal 
end of a 1 mm diameter coherent fiber-optic bundle (Sumitomo, IGN-08/30). The distal 
end of the bundle is placed in direct contact with the sample to collect fluorescence 
emission, which then returns through the bundle and is imaged on to the optical sensor of 
the digital camera by a 20×/0.40 NA infinity-corrected objective lens (Olympus) and a 
150 mm tube lens. For proflavine (Sigma, P2580) used as a contrast agent, a 500 nm 
long-pass filter (Thorlabs, FEL0500) was placed in infinity space. The objective and the 
tube lens combination form a magnified image of the bundle on the sensor of the camera, 
which is visualized on the LCD screen of the camera in real-time. The camera also allows 
connection to a laptop or other monitor screen through USB or composite video cables. 
The entire system weighs 3.5 pounds, is powered by a rechargeable battery, and operates 
for about one hour on a single charge. The overall cost of the system is about $2,000 
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including the $400 digital SLR camera body. The SLR camera specifications are 
summarized and compared with those of the scientific-grade CCD camera used by 
Muldoon et al. [32] in Table 1. 
 
Figure 11.  High-resolution fiber-optic microendoscope. (A) Schematic diagram of the system. (B) 
Photograph of the system. 
 
Table 4.  Experimental parameters of systems. 
 Olympus E-330 Muldoon et al. [32] 
Array size (mm) 17.3 x 13.0 10.2 x 8.3 
Pixel size (µm) 5.6 x 5.6 6.45 x 6.45 
Number of pixels 3136 x 2352 1392 x 1040 
Relay magnification 19.5 x 8.3 x 
Pixels per fiber at CCD 7.68 2.85 
CCD dynamic range 43 dB 67 dB 
 
Cell culture and labeling 
Proflavine is a fluorescent stain which labels cell nuclei by intercalating between 
DNA base pairs [44]. Absorption and emission maxima are at approximately 445 and 510 
nm, respectively. 1483 oral cancer cells derived from a human oropharyngeal squamous 
carcinoma were stained with proflavine (0.01% w/v in PBS, Sigma P2508) and then 
suspended in collagen for imaging. 
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Surgical specimen acquisition and imaging 
Through a study protocol approved by both Rice University and the University of 
Texas M.D. Anderson Cancer Center Institutional Review Boards, and following written 
informed consent by the patient, a surgical specimen was obtained immediately after 
resection. Following topical application of proflavine (0.01% w/v in PBS, Sigma P2508) 
to the mucosal surface, images were obtained with the fiber-optic microendoscope. The 
specimen was sent for routine histopathology; H&E sections were prepared, including 
from the sites imaged with the fiber-optic microendoscope. Proflavine staining does not 
affect subsequent H&E staining for histologic analysis. 
Human subject imaging 
The oral mucosa of a healthy human subject who had given written informed 
consent was imaged in vivo using the fiber-optic microendoscope in accordance with a 
protocol approved by the Rice University Institutional Review Board. The participant in 
this manuscript has given written informed consent (as outlined in the PLoS consent 
form) to publication of his/her case details. Proflavine was obtained in powder form from 
Sigma (P2508) and prepared in solution for imaging by dissolving in PBS (0.01% w/v) 
and sterile filtered prior to use. Proflavine was topically applied to a small area of the 
mucosal surface. After only a few seconds of application, the distal tip of the fiber-optic 
bundle was placed in direct contact. Real-time observation of sub-cellular detail at the 
imaged site was possible via the camera's LCD screen (Figure 11 (B)). Images recorded 
for additional analysis were stored on the camera's removable memory card. 
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9.3  Results 
System characterization 
Spatial resolution was measured by imaging a Ronchi grating and calculating the 
distance across the edge over which intensity ranged from 10% to 90% of the maximal 
value. The 10±90% distance was found to be 5.0 µm. The spatial resolution is currently 
limited by under-sampling due to the 4 µm core-core spacing between individual 
elements in the coherent fiber-optic bundle; Figure 12 shows that the system can resolve 
the G6 E6 lines of a USAF resolution target (line width = 4.4 µm). The size of the 
individual fibers is 2.2 µm and there are approximately 30,000 fibers in the bundle. We 
assessed the depth-of-field of the system by measuring images of a USAF resolution 
target as the distance between the fiber tip and the surface of the target was increased. 
Results show that the depth of focus is approximately 20 µm, based on the distance at 
which the contrast between the G6 E6 lines was reduced to 26% of its maximal value 
(Rayleigh). The imaged field-of-view corresponds to the physical area of the fiber bundle 
face, which is 800 µm in diameter. In the system presented here, the fiber-bundle image 
slightly overfills the sensor of the camera, resulting in an achieved field-of-view of 660 
µm. The optical power delivered to the distal tip of the fiber bundle was measured to be 
0.5 mW, corresponding to an average irradiance level of 100 mW/cm2. 
1483 oral cancer cell imaging 
Images of 1483 oral cancer cells labeled with proflavine obtained using the fiber-optic 
microendoscope are shown in Figure 13. Owing to labeling with proflavine, cell nuclei 
appear bright in the image. Images acquired with the SLR-based system (Figure 13 (A)) 
were compared to those obtained with a scientific CCD-based microendoscope (Figure 3 
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(B)) [32], with both images acquired at the same sample site, under identical illumination 
conditions. The power measured from the fiber bundle was 0.5 mW for each image. We 
summarized the experimental parameters of these two microendoscope systems in Table 
1. The SLR-based image (Figure 13 (A)) was taken with a 1 second integration time at 
the lowest ISO setting (ISO 100). The CCD-based image (Figure 13 (B)) was taken with 
a 1 second integration time at 0 dB gain. Each image was separated into labeled (signal) 
and unlabeled (background) regions in software by setting an intensity-based threshold. 
The average grayscale intensity of the pixels in the labeled regions in the SLR-based 
image was 80.4. The corresponding average intensity in the CCD-based image was 138.9. 
The signal-to-background ratio measured in the SLR-based image was 2.88 and 3.67 in 
the CCD-based image. The average pixel intensity of the black level measured in the 
SLR-based system was 2.3 and 5.6 in the CCD-based system; it is not possible to 
manually adjust the offset level in either system. 
 
 
Figure 12.  USAF resolution target image. 
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Figure 13.  1483 oral cancer cell images using proflavine as a contrast agent to visualize cell nuclei. (A) 
Image acquired with the SLR-based microendoscope. (B) Image acquired with the scientific CCD-based 
microendoscope. 
 
Ex vivo human specimen imaging 
Images obtained from a surgically resected oral tissue specimen containing an 
oral squamous carcinoma located in the right posterior floor of mouth are shown in 
Figure 4. Each image was acquired with a 0.25 s integration time and ISO 400. The distal 
tip of the fiber-optic bundle was placed in direct contact with the specimen at regions 
appearing clinically normal and abnormal, as shown in the accompanying photographs. 
In microendoscope images, regularly-distributed nuclei appear as discrete, bright dots 
throughout the field-of-view at the clinically-normal region (Figure 14 (A)). Near the 
tumor margin, the nuclear density exhibited the characteristic increase associated with 
neoplastic progression (Figure 14 (B)). The image obtained at the region containing the 
tumor demonstrates the characteristic features associated with cancer such as dense and 
disorganized nuclei (Figure 14 (C)). From the microendoscope images, we quantified the 
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nuclear-to-cytoplasmic (N/C) area ratio, which is an important parameter used in the 
 
Figure 14.  Ex vivo human specimen imaging. (A) Normal epithelium. Left; photograph of fiber bundle 
probe in contact with resected tissue at clinically-normal region. Yellow border represents margin of 
clinically-abnormal region identified by the surgeon. Center; image taken with fiber-optic microendoscope. 
Scale bar represents 100mm. Light; corresponding histopathology section demonstrating normal epithelium. 
(B) Mild dysplasia. Probe placed at region near to margin of tumor (left). Corresponding histopathology 
section demonstrates mild dysplasia. (C) Cancer. Probe placed at clinically-abnormal region. 
Corresponding histopathology section demonstrates squamous carcinoma. (D) Calculated N/C ratio of 
images in (A, B and C). The dashed line represents an N/C ratio of 0.08. 
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histological diagnosis of cancer. Using morphological image processing methods, nuclei 
were segmented based on a pixel intensity threshold, defining nuclear and cytoplasmic 
regions. N/C ratio was then calculated from the number of pixels in each region. The N/C 
ratio for the images shown in Figure 14 (A, B and C) was calculated to be 0.06, 0.12 and 
0.34 respectively (Figure 14 (D)), which may be compared to the threshold value of 0.08, 
established by Collier et al. as a means of discriminating between normal (lower N/C 
ratio) and cervical intraepithelial neoplasia (higher N/C ratio) [71]. The corresponding 
histology in Figure 14 (A) demonstrates normal epithelium, while Figure 14 (B) indicates 
mild dysplasia and Figure 14 (C) indicates squamous carcinoma. 
In vivo human subject imaging 
Figure 15 demonstrates the characteristics of normal human oral mucosa imaged 
in vivo, including bright and regularly-distributed nuclei labeled by proflavine. The 
calculated N/C ratio for this image is 0.05. The image presented in Figure 5 (B) is a 
single frame acquired during real-time imaging at 4 frames per second. 
9.4  Discussion 
Several studies have previously investigated the use of compact digital cameras or cell 
phone cameras for biomedical imaging applications. Consumer-grade cameras have been 
used for wide-field fluorescence imaging [66-69], pathology analysis [70], and the on-
board cameras of cell phones [72-76] and PDAs [77] have been used in clinical 
applications. Here we demonstrated a portable high-resolution fiber-optic fluorescence 
imaging system for in vivo cellular imaging. The system leverages the increasing level of 
imaging performance which has become accessible at relatively low-cost through the 
consumer electronics market. The use of a digital camera has several practical benefits; 
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the system incorporates an LCD screen for real-time image visualization, thus eliminating 
the requirement for additional hardware for image processing and display. While digital 
camera displays have increased in size and resolution in recent years, many cameras can 
also transmit images to a larger external monitor via USB or composite video cables. 
Digital camera units are also battery-powered, enabling a completely portable imaging 
system to be assembled. 
 
 
Figure 15.  In vivo image of human volunteer. 
  
The images obtained here were obtained using the contrast agent, proflavine. 
Proflavine is inexpensive, has a long history of safe clinical use, and fluorescence images 
of epithelial cells can be obtained with high contrast between the cytoplasm and nucleus 
within seconds after topical application. Proflavine is the principal component of 
acriflavine and has been used for fluorescence imaging in the European, Asian, and 
Australian gastrointestinal literature without any adverse effects noted [78]. Moreover, 
proflavine has been used clinically as an antibacterial agent for decades. In neonatal care, 
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Triple dye, a combination of brilliant green, proflavine hemisulfate, and gentian violet is 
routinely used as a topical antibacterial agent on the umbilical stump of newborn babies 
[79], with a recent review of the practice categorizing toxicity as rare [80]. The 
concentrations of proflavine solution required for successful imaging (0.01±0.05%) [78] 
are substantially lower than that of the proflavine component in commercial triple dye, 
0.11% (w/v) (VistaPharm, Kerr Triple Dye). The quantity of solution required for 
diagnostic imaging is approximately the same as that used in neonatal care (0.65 ml per 
single-use swab). The additional exposure to light which will occur during imaging can 
also be compared to that received by newborn babies undergoing phototherapy for 
jaundice. The high-resolution fiber-optic microendoscope proposed for use here delivers 
0.5 mW of 455 nm light to the tissue through a 0.8 mm diameter fiber-optic bundle, 
corresponding to an irradiance level of 100 mW/cm2. The American Academy of 
Pediatrics defines intensive phototherapy as a spectral irradiance of at least 30 W/cm2 per 
nanometer over the 430±490 nm spectral band, equivalent to a total irradiance of 1.8 
mW/cm2 [81]. Although the irradiance level is over 50-times higher with the fiber 
microendoscope system, a typical imaging session of 30 minutes (including imaging for 
routine care) is approximately 50-times shorter than a typical 24 hour (1440 minutes) 
phototherapy incubation, leading to an equivalent light dose in each scenario. Proflavine 
has also been safely used in previous clinical studies evaluating its effect as a 
photosensitizing agent for the treatment of genital herpes simplex virus [82]. Precancers 
of the epithelium are associated with a variety of morphological changes including 
increased nuclear size, pleomorphism, nuclear hyperchromasia and increased N/C ratio 
[83]. Clinical pathologists currently assess these features qualitatively, by examining 
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stained sections at low and high power magnification. Recently, a number of studies have 
shown that quantitative analysis of digital images of stained histologic sections can aid in 
the identification of precancers [84]. In quantitative pathology, measurements of 
morphological and architectural features are used to make the diagnosis. In both cases, 
the morphologic information is acquired from stained tissue sections taken from biopsies, 
which are invasive, expensive, and painful and limit the area at risk which can be 
examined. In vivo microscopy provides an alternative approach to assess these 
morphologic changes in vivo. For example, nuclear morphometry acquired from two 
dimensional confocal images of the cervical epithelium can be used to distinguish normal 
epithelium from high grade dysplasia in the cervix [85]. 
As high resolution in vivo imaging systems such as the one presented here 
achieve more widespread clinical application, there is a growing need for image atlases to 
help clinicians and pathologists interpret these types of images. Such tools are beginning 
to be developed. For example, the Digital Atlas of Video Endoscopy (DAVE) is an 
endoscopic education tool containing both high-resolution images and videos of different 
gastrointestinal procedures and disorders. Developed in collaboration with the American 
Society of Gastrointestinal Endoscopy (ASGE), the largest endoscopic society worldwide, 
the DAVE project serves as an initial and free platform for dissemination to the public 
[86]. 
Modern digital cameras are also capable of on-board image processing. 
Pathologically relevant morphologic markers including nuclear size, distribution, and 
N/C ratio could potentially be extracted from images using relatively straightforward 
analysis algorithms. This information could be used to assist non-expert medical 
58 
 
personnel in reaching a diagnosis, by providing quantitative evaluation of images in real-
time. Alternatively, the same information could be used to guide the healthcare provider 
in biopsy site selection, by locating those sites with the highest suspicion for disease. The 
flash memory cards used for image storage are also widely compatible with cell phone 
and PDA hardware, enabling image transmission to remote experts in situations where 
further diagnostic interpretation is necessary. 
A potential clinical application area for this type of cost-effective, compact 
imaging system may emerge in early cancer screening, particularly in developing 
countries. In the foreseeable future, the burden of cancer will continue to shift onto the 
populations of these regions, where early detection through screening programs offers the 
only opportunity to implement affordable treatment. Real-time diagnosis at the time of a 
clinical visit is also critical in reducing loss of patients to follow-XSDQGHQDEOHV³VHH-
and-WUHDW´ SURJUDPV WR EH FDUULHG RXW 6HYHUDO HSLWKHOLDO FDQFHUV VXFK DV WKRVH RI WKH
uterine cervix, oral cavity, and esophagus are significant contributors to mortality and 
morbidity in developing countries, and a high-resolution in vivo imaging system such as 
the one presented here could have significant impact on the management of these cancers. 
In conclusion, we believe that recent advances in imaging performance coupled 
with declining costs will enable further development of clinically viable diagnostic 
imaging systems based upon consumer-grade electronics. Such instruments may find use 
in developing countries with limited technical and financial resources, or in industrialized 
nations with inefficient, overpriced healthcare systems. 
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6.  CONCLUSION 
In summary, several clinical studies were performed to evaluate the effectiveness of 
quantitative classification algorithms for HRME images to distinguish between 
esophageal neoplastic and non-neoplastic tissue. A study of HRME in 177 patients with 
ESCC resulted in a sensitivity and specificity of 93% and 92%, respectively, in the 
training set, 87% and 97%, respectively, in the test set, and 84% and 95%, respectively, 
in an independent validation set using mean nuclear area as the basis for classification. 
Another study in 31 patients with esophageal BE resulted in a sensitivity of 84% and a 
specificity of 85% using a sequential quantitative classification algorithm. Given the 
diagnostic performances of HRME and quantitative classification algorithms in these 
studies, there was a need for a more portable and cost-effective system with comparable 
performance to the existing HRME. A portable fiber-optic microendoscope using a 
consumer-grade digital camera was developed, and a series of biomedical experimental 
studies were performed to evaluate the capability and portability of the device. 
 The results reported here confirm that HRME with a classification algorithm can 
be a useful tool for screening and surveillance of esophageal neoplasia. Automated 
analysis of microendoscopic images can potentially provide an objective quantitative 
means to assist clinicians in evaluating esophageal lesions. Combined with the portable 
fiber-optic microendoscope based on a consumer-grade camera, the quantitative 
classification algorithm can be used, particularly in low-resource settings. Challenges that 
remain for the use of HRME with the classification algorithm in a clinical setting include 
implementing a fully-automated image analysis of the entire process and evaluating its 
diagnostic performance in vivo. To address these challenges, it will be necessary to 
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automate the entire process by implementing automated frame selection and QC 
procedures and to embed the quantitative classification algorithm in the HRME imaging 
software for real-time diagnosis. Alternatively, a visual interpretation guide was created 
based on the quantities found in the algorithm to assist clinicians in detecting esophageal 
neoplasia in real-time during endoscopy. Another challenge includes the proper use of 
cost-effective consumer-grade electronics in the imaging system. Given the rapid 
improvements in these electronics, this challenge can be effectively addressed using 
appropriate technology; for example, the camera of a cellular phone can be used as a 
cost-effective imaging system, which can then be coupled with the quantitative analysis 
algorithm based on open-source principles. 
High-resolution imaging combined with quantitative analysis may enhance the 
performance of optical imaging for real-time objective detection of esophageal neoplastic 
lesions during endoscopy. While this computer-aided diagnostic imaging system has 
yielded interesting results, it has not yet been evaluated in low-resource settings. As such, 
future studies will need to evaluate the cost-effectiveness of this technique in such 
settings.  
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